Exploring the New Frontiers of Cannabis: 10-OH-HHC and 10-OH-HHCP

The cannabis industry is constantly evolving, with new compounds emerging and gaining attention for their unique properties and potential benefits. Two of the latest cannabinoids making waves are 10-OH-HHC and 10-OH-HHCP. In this blog post, we’ll delve into what these compounds are, how they compare to well-known cannabinoids, and what sets them apart in the cannabis market.

Continue ReadingExploring the New Frontiers of Cannabis: 10-OH-HHC and 10-OH-HHCP

The New German Amendment Proposal: Implications for Cannabinoid Companies in the German Market

The German Ministry of Health has recently proposed an amendment to the New Psychoactive Substances Act (NpSG), which aims to address the emergence of new chemical variants of psychoactive substances (NPS). This move is set to have significant implications for cannabinoid companies operating in the German market.

Continue ReadingThe New German Amendment Proposal: Implications for Cannabinoid Companies in the German Market

“Navigating the New Wave: The Transition from HHC to 10-OH-HHC in Europe’s Evolving Cannabinoid Landscape

The landscape of cannabis-derived products is undergoing significant changes in Europe, with regulatory shifts that are altering the availability and legal status of certain cannabinoids. One such development is the increasing scrutiny and subsequent bans on specific cannabinoids, such as hexahydrocannabinol (HHC), across various European countries. In response to these regulatory challenges, the cannabis industry is continually innovating, leading to the emergence of new compounds like 10-hydroxyhexahydrocannabinol (10-OH-HHC), which is being touted as a safer and legal alternative with effects similar to those of its predecessors.

Continue Reading“Navigating the New Wave: The Transition from HHC to 10-OH-HHC in Europe’s Evolving Cannabinoid Landscape